LiteFold/IEDB huggingface dataset:
Reference: Alexander A Cohen; Neeltje van Doremalen; Allison J Greaney; Hanne Andersen; Ankur Sharma; Tyler N Starr; Jennifer R Keeffe; Chengcheng Fan; Jonathan E Schulz; Priyanthi N P Gnanapragasam; Leesa M Kakutani; Anthony P West; Greg Saturday; Yu E Lee; Han Gao; Claudia A Jette; Mark G Lewis; Tiong K Tan; Alain R Townsend; Jesse D Bloom; Vincent J Munster; Pamela J Bjorkman. "Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models." Science (New York, N.Y.) (2022).

Epitope: SARS CoV2 S K484
Chemical type: Discontinuous protein residues
Discontinuous residues: K481
Source molecule (GenBank): QWW93436.1
Assay category: BCell
Result: Positive
Host: F 7-8 weeks

Epitope: SARS CoV2 S K484
Chemical type: Discontinuous protein residues
Discontinuous residues: K481
Source molecule (GenBank): QWW93436.1
Assay category: BCell
Result: Positive
Host:  3-5 years

Epitope: SARS CoV2 S S383
Chemical type: Discontinuous protein residues
Discontinuous residues: S380
Source molecule (GenBank): QWW93436.1
Assay category: BCell
Result: Positive
Host:  3-5 years

Epitope: SARS CoV2 S S383
Chemical type: Discontinuous protein residues
Discontinuous residues: S380
Source molecule (GenBank): QWW93436.1
Assay category: BCell
Result: Positive
Host: F 7-8 weeks

Epitope: SARS CoV2 S P384
Chemical type: Discontinuous protein residues
Discontinuous residues: P381
Source molecule (GenBank): QWW93436.1
Assay category: BCell
Result: Positive
Host: F 7-8 weeks

Epitope: SARS CoV2 S P384
Chemical type: Discontinuous protein residues
Discontinuous residues: P381
Source molecule (GenBank): QWW93436.1
Assay category: BCell
Result: Positive
Host:  3-5 years

Epitope: SARS CoV2 S K386
Chemical type: Discontinuous protein residues
Discontinuous residues: K383
Source molecule (GenBank): QWW93436.1
Assay category: BCell
Result: Positive
Host:  3-5 years

Epitope: SARS CoV2 S K386
Chemical type: Discontinuous protein residues
Discontinuous residues: K383
Source molecule (GenBank): QWW93436.1
Assay category: BCell
Result: Positive
Host: F 7-8 weeks

Epitope: SARS CoV2 S R357
Chemical type: Discontinuous protein residues
Discontinuous residues: R354
Source molecule (GenBank): QWW93436.1
Assay category: BCell
Result: Positive
Host:  3-5 years

Epitope: SARS CoV2 S R357
Chemical type: Discontinuous protein residues
Discontinuous residues: R354
Source molecule (GenBank): QWW93436.1
Assay category: BCell
Result: Positive
Host: F 7-8 weeks

Epitope: SARS CoV2 S I468
Chemical type: Discontinuous protein residues
Discontinuous residues: I465
Source molecule (GenBank): QWW93436.1
Assay category: BCell
Result: Positive
Host: F 7-8 weeks

Epitope: SARS CoV2 S T500
Chemical type: Discontinuous protein residues
Discontinuous residues: T497
Source molecule (GenBank): QWW93436.1
Assay category: BCell
Result: Positive
Host:  3-5 years
Reference: Federico Ballabio; Luca Broggini; Cristina Paissoni; Xiao Han; Kaliroi Peqini; Benedetta Maria Sala; Renhua Sun; Tatyana Sandalova; Alberto Barbiroli; Adnane Achour; Sara Pellegrino; Stefano Ricagno; Carlo Camilloni. "l- to d-Amino Acid Substitution in the Immunodominant LCMV-Derived Epitope gp33 Highlights the Sensitivity of the TCR Recognition Mechanism for the MHC/Peptide Structure and Dynamics." ACS omega (2022).

Epitope: gp33, wild-type
Chemical type: Peptide, no natural source
Sequence: KAVYNFATM
Assay category: TCell
Result: Positive
Quantitative measurement: 6300.0

Epitope: gp33, wild-type
Chemical type: Peptide, no natural source
Sequence: KAVYNFATM
Assay category: MhcBinding
Result: Positive
Quantitative measurement: 63.5

Epitope: gp33-V3P
Chemical type: Peptide, no natural source
Sequence: KAPYNFATM
Assay category: TCell
Result: Positive
Quantitative measurement: 1800.0

Epitope: gp33-V3P
Chemical type: Peptide, no natural source
Sequence: KAPYNFATM
Assay category: MhcBinding
Result: Positive
Quantitative measurement: 66.0

Epitope: gp33-V3P_F6f  (KAPYNfATM)
Chemical type: Peptide, no natural source
Sequence: KAPYNFATM
Assay category: TCell
Result: Positive
Quantitative measurement: 44000.0

Epitope: gp33-V3P_F6f  (KAPYNfATM)
Chemical type: Peptide, no natural source
Sequence: KAPYNFATM
Assay category: MhcBinding
Result: Positive
Quantitative measurement: 64.0

Epitope: gp33-V3P_F6f  (KAPYNfATM)
Chemical type: Peptide, no natural source
Sequence: KAPYNFATM
Assay category: MhcBinding
Result: Positive
Quantitative measurement: 2.43
Reference: Diane Manry; Kristian Bolanos; Breanna DiAndreth; Jee-Young Mock; Alexander Kamb. "Robust  Pharmacology of Tmod, a Synthetic Dual-Signal Integrator for Cancer Cell Therapy." Frontiers in immunology (2022).

Epitope: KRAS mutant peptide (8-17)
Chemical type: Peptide, no natural source
Sequence: VVVGAVGVGK
Assay category: TCell
Result: Positive
Cell type: Jurkat cell (T cell)
Tissue: blood
Culture conditions: Engineered

Epitope: KRAS mutant peptide (8-17)
Chemical type: Peptide, no natural source
Sequence: VVVGAVGVGK
Assay category: MhcBinding
Result: Positive
Reference: Zengchao Sun; Lu Wang; Xiyang Li; Chengpeng Fan; Jianfeng Xu; Zhenzhong Shi; Huarui Qiao; Zhongyun Lan; Xin Zhang; Lingyun Li; Xin Zhou; Yong Geng. "An extended conformation of SARS-CoV-2 main protease reveals allosteric targets." Proceedings of the National Academy of Sciences of the United States of America (2022).

Epitope: Epitope of NB1A2 on SARS-CoV-2 M pro
Chemical type: Discontinuous protein residues
Discontinuous residues: T3288, T3289, H3304, C3307, T3308, S3309, E3310, M3312, L3313, N3405, G3406, C3408, M3428, E3429, L3430, P3431, T3432, R3451, Q3452, T3453, A3454, Q3455
Source molecule (GenBank): P0DTC1.1
Assay category: BCell
Result: Positive
Quantitative measurement: 1.75

Epitope: Epitope of NB1A2 on SARS-CoV-2 M pro
Chemical type: Discontinuous protein residues
Discontinuous residues: T3288, T3289, H3304, C3307, T3308, S3309, E3310, M3312, L3313, N3405, G3406, C3408, M3428, E3429, L3430, P3431, T3432, R3451, Q3452, T3453, A3454, Q3455
Source molecule (GenBank): P0DTC1.1
Assay category: BCell
Result: Positive

Epitope: Epitope of NB1A2 on SARS-CoV-2 M pro
Chemical type: Discontinuous protein residues
Discontinuous residues: T3288, T3289, H3304, C3307, T3308, S3309, E3310, M3312, L3313, N3405, G3406, C3408, M3428, E3429, L3430, P3431, T3432, R3451, Q3452, T3453, A3454, Q3455
Source molecule (GenBank): P0DTC1.1
Assay category: BCell
Result: Positive
Quantitative measurement: 2.426

Epitope: Epitope of NB2B4 on SARS-CoV-2 M pro
Chemical type: Discontinuous protein residues
Discontinuous residues: A3473, I3476, N3477, T3543, L3545, G3546, S3547, L3549, E3551, E3553, F3554, F3557, D3558, R3561, Q3562, C3563, V3566
Source molecule (GenBank): P0DTC1.1
Assay category: BCell
Result: Positive
Quantitative measurement: 2.0

Epitope: Epitope of NB2B4 on SARS-CoV-2 M pro
Chemical type: Discontinuous protein residues
Discontinuous residues: A3473, I3476, N3477, T3543, L3545, G3546, S3547, L3549, E3551, E3553, F3554, F3557, D3558, R3561, Q3562, C3563, V3566
Source molecule (GenBank): P0DTC1.1
Assay category: BCell
Result: Positive

Epitope: Epitope of NB2B4 on SARS-CoV-2 M pro
Chemical type: Discontinuous protein residues
Discontinuous residues: A3473, I3476, N3477, T3543, L3545, G3546, S3547, L3549, E3551, E3553, F3554, F3557, D3558, R3561, Q3562, C3563, V3566
Source molecule (GenBank): P0DTC1.1
Assay category: BCell
Result: Positive
Quantitative measurement: 0.461
Reference: Yanyun Du; Rui Shi; Ying Zhang; Xiaomin Duan; Li Li; Jing Zhang; Fengze Wang; Ruixue Zhang; Hao Shen; Yue Wang; Zheng Wu; Qianwen Peng; Ting Pan; Wanwei Sun; Weijin Huang; Yue Feng; Hui Feng; Junyu Xiao; Wenjie Tan; Youchun Wang; Chenhui Wang; Jinghua Yan. "A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants." Nature communications (2021).

Epitope: Epitope of h11B11 on hACE2
Chemical type: Discontinuous protein residues
Discontinuous residues: Q24, A25, T27, F28, K31, M82, Y83
Source molecule (GenBank): Q9BYF1.2
Assay category: BCell
Result: Positive
Quantitative measurement: 27700.0

Epitope: Epitope of h11B11 on hACE2
Chemical type: Discontinuous protein residues
Discontinuous residues: Q24, A25, T27, F28, K31, M82, Y83
Source molecule (GenBank): Q9BYF1.2
Assay category: BCell
Result: Positive
Quantitative measurement: 0.0000788

Epitope: Epitope of h11B11 on hACE2
Chemical type: Discontinuous protein residues
Discontinuous residues: Q24, A25, T27, F28, K31, M82, Y83
Source molecule (GenBank): Q9BYF1.2
Assay category: BCell
Result: Positive
Quantitative measurement: 4.39

Epitope: Epitope of h11B11 on hACE2
Chemical type: Discontinuous protein residues
Discontinuous residues: Q24, A25, T27, F28, K31, M82, Y83
Source molecule (GenBank): Q9BYF1.2
Assay category: BCell
Result: Positive
Quantitative measurement: 30700.0

Epitope: Epitope of h11B11 on hACE2
Chemical type: Discontinuous protein residues
Discontinuous residues: Q24, A25, T27, F28, K31, M82, Y83
Source molecule (GenBank): Q9BYF1.2
Assay category: BCell
Result: Positive
Quantitative measurement: 0.000135

Epitope: Epitope of h11B11 on hACE2
Chemical type: Discontinuous protein residues
Discontinuous residues: Q24, A25, T27, F28, K31, M82, Y83
Source molecule (GenBank): Q9BYF1.2
Assay category: BCell
Result: Positive
Quantitative measurement: 3.8

Epitope: Epitope of h11B11 on hACE2
Chemical type: Discontinuous protein residues
Discontinuous residues: Q24, A25, T27, F28, K31, M82, Y83
Source molecule (GenBank): Q9BYF1.2
Assay category: BCell
Result: Positive

Epitope: Epitope of h11B11 on hACE2
Chemical type: Discontinuous protein residues
Discontinuous residues: Q24, A25, T27, F28, K31, M82, Y83
Source molecule (GenBank): Q9BYF1.2
Assay category: BCell
Result: Positive

Epitope: Epitope of h11B11 on hACE2
Chemical type: Discontinuous protein residues
Discontinuous residues: Q24, A25, T27, F28, K31, M82, Y83
Source molecule (GenBank): Q9BYF1.2
Assay category: BCell
Result: Positive
Quantitative measurement: 2.95
Reference: C D Lemke; J B Graham; D M Lubaroff; A K Salem. "Development of an MHC class I L(d)-restricted PSA peptide-loaded tetramer for detection of PSA-specific CD8+ T cells in the mouse." Prostate cancer and prostatic diseases (2011).

Epitope: hPSA 188-197
Chemical type: Peptide from protein
Sequence: HPQKVTKFML
Position: 188-197
Source molecule (GenBank): P07288.2
Assay category: TCell
Result: Negative
Host: M 
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: hPSA 188-197
Chemical type: Peptide from protein
Sequence: HPQKVTKFML
Position: 188-197
Source molecule (GenBank): P07288.2
Assay category: TCell
Result: Positive
Host: M 
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: hPSA 188-197
Chemical type: Peptide from protein
Sequence: HPQKVTKFML
Position: 188-197
Source molecule (GenBank): P07288.2
Assay category: TCell
Result: Positive
Host: M 
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: hPSA 188-197
Chemical type: Peptide from protein
Sequence: HPQKVTKFML
Position: 188-197
Source molecule (GenBank): P07288.2
Assay category: TCell
Result: Negative
Host: M 
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo
Reference: Norihiko Takahashi; Takayuki Ohkuri; Shigenori Homma; Junya Ohtake; Daiko Wakita; Yuji Togashi; Hidemitsu Kitamura; Satoru Todo; Takashi Nishimura. "First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer-hybrid epitope long peptide of MAGE-A4 cancer antigen." Cancer science (2012).

Epitope: MAGE-A4-H/K-HELP
Chemical type: Peptide, no natural source
Sequence: NYKRCFPVIFGKGGGGGGALAETSYVKVLEHVVRVNARVR
Assay category: BCell
Result: Positive
Host: M 62 years

Epitope: MAGE-A4-H/K-HELP
Chemical type: Peptide, no natural source
Sequence: NYKRCFPVIFGKGGGGGGALAETSYVKVLEHVVRVNARVR
Assay category: BCell
Result: Positive-Low
Host: M 62 years

Epitope: MAGE-A4-H/K-HELP
Chemical type: Peptide, no natural source
Sequence: NYKRCFPVIFGKGGGGGGALAETSYVKVLEHVVRVNARVR
Assay category: BCell
Result: Negative
Host: M 62 years

Epitope: MAGE-A4-H/K-HELP
Chemical type: Peptide, no natural source
Sequence: NYKRCFPVIFGKGGGGGGALAETSYVKVLEHVVRVNARVR
Assay category: BCell
Result: Negative
Host: M 62 years

Epitope: MAGE-A4-H/K-HELP
Chemical type: Peptide, no natural source
Sequence: NYKRCFPVIFGKGGGGGGALAETSYVKVLEHVVRVNARVR
Assay category: TCell
Result: Positive
Host: M 62 years
Cell type: T cell CD4+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: MAGE-A4-H/K-HELP
Chemical type: Peptide, no natural source
Sequence: NYKRCFPVIFGKGGGGGGALAETSYVKVLEHVVRVNARVR
Assay category: TCell
Result: Positive
Host: M 62 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: MAGE-A4-H/K-HELP
Chemical type: Peptide, no natural source
Sequence: NYKRCFPVIFGKGGGGGGALAETSYVKVLEHVVRVNARVR
Assay category: TCell
Result: Negative
Host: M 62 years
Cell type: T cell CD4+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: MAGE-A4-H/K-HELP
Chemical type: Peptide, no natural source
Sequence: NYKRCFPVIFGKGGGGGGALAETSYVKVLEHVVRVNARVR
Assay category: TCell
Result: Negative
Host: M 62 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: MAGE-A4-H/K-HELP
Chemical type: Peptide, no natural source
Sequence: NYKRCFPVIFGKGGGGGGALAETSYVKVLEHVVRVNARVR
Assay category: TCell
Result: Positive
Host: M 62 years
Reference: Kamila Wojas-Krawczyk; Paweł Krawczyk; Jarosław Buczkowski; Anna Walkowska; Olga Jankowska; Elżbieta Czekajska-Chehab; Janusz Milanowski. "Immunotherapy of lung adenocarcinoma patient with Peptide-pulsed dendritic cells: a case report." Archivum immunologiae et therapiae experimentalis (2012).

Epitope: MUC-1 M1.1
Chemical type: Peptide from protein
Sequence: STAPPVHNV
Position: 957-965
Source molecule (GenBank): A0A087WWM1
Assay category: TCell
Result: Negative
Host: M 60 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: MUC-1 M1.1
Chemical type: Peptide from protein
Sequence: STAPPVHNV
Position: 957-965
Source molecule (GenBank): A0A087WWM1
Assay category: TCell
Result: Positive
Host: M 60 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: MUC-1 M1.2
Chemical type: Peptide from protein
Sequence: LLLLTVLTV
Position: 12-20
Source molecule (GenBank): A0A087WWM1
Assay category: TCell
Result: Positive
Host: M 60 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: MUC-1 M1.2
Chemical type: Peptide from protein
Sequence: LLLLTVLTV
Position: 12-20
Source molecule (GenBank): A0A087WWM1
Assay category: TCell
Result: Negative
Host: M 60 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo
Reference: Aaron P Rapoport; Nicole A Aqui; Edward A Stadtmauer; Dan T Vogl; Yin Yan Xu; Michael Kalos; Ling Cai; Hong-Bin Fang; Brendan M Weiss; Ashraf Badros; Saul Yanovich; Gorgun Akpek; Patricia Tsao; Alan Cross; Dean Mann; Sunita Philip; Naseem Kerr; Andrea Brennan; Zhaohui Zheng; Kathleen Ruehle; Todd Milliron; Scott E Strome; Andres M Salazar; Bruce L Levine; Carl H June. "Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells." Clinical cancer research : an official journal of the American Association for Cancer Research (2014).

Epitope: CTL1
Chemical type: Peptide from protein
Sequence: KVAELVHFL
Position: 112-120
Source molecule (GenBank): P43357.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: GL-0187
Chemical type: Peptide, no natural source
Sequence: KVAELVHFLRVKRFLWGPRALVRVKRVIFSKASSSLQLRKKRRQRRR
Assay category: BCell
Result: Positive

Epitope: GL-0187
Chemical type: Peptide, no natural source
Sequence: KVAELVHFLRVKRFLWGPRALVRVKRVIFSKASSSLQLRKKRRQRRR
Assay category: TCell
Result: Positive-Low
Cell type: T cell CD4+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: GL-0187
Chemical type: Peptide, no natural source
Sequence: KVAELVHFLRVKRFLWGPRALVRVKRVIFSKASSSLQLRKKRRQRRR
Assay category: TCell
Result: Positive-Low
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: GL-0187
Chemical type: Peptide, no natural source
Sequence: KVAELVHFLRVKRFLWGPRALVRVKRVIFSKASSSLQLRKKRRQRRR
Assay category: TCell
Result: Positive

Epitope: GL-0187
Chemical type: Peptide, no natural source
Sequence: KVAELVHFLRVKRFLWGPRALVRVKRVIFSKASSSLQLRKKRRQRRR
Assay category: TCell
Result: Positive
Cell type: T cell CD4+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: GL-0187
Chemical type: Peptide, no natural source
Sequence: KVAELVHFLRVKRFLWGPRALVRVKRVIFSKASSSLQLRKKRRQRRR
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: HTL
Chemical type: Peptide from protein
Sequence: VIFSKASSSLQL
Position: 149-160
Source molecule (GenBank): P43357.1
Assay category: TCell
Result: Positive
Cell type: T cell CD4+
Tissue: blood
Culture conditions: Short Term Restimulated
Reference: Yunyan Wu; Meixiang Sang; Fei Liu; Jiandong Zhang; Weijing Li; Zhenhua Li; Lina Gu; Yang Zheng; Juan Li; Baoen Shan. "Epigenetic modulation combined with PD-1/PD-L1 blockade enhances immunotherapy based on MAGE-A11 antigen-specific CD8+T cells against esophageal carcinoma." Carcinogenesis (2020).

Epitope: MAGE-A11
Chemical type: Peptide from protein
Sequence: FLFGEPKRL
Position: 350-358
Source molecule (GenBank): P43364.2
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: MAGE-A11
Chemical type: Peptide from protein
Sequence: FLFGEPKRL
Position: 350-358
Source molecule (GenBank): P43364.2
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: MAGE-A11
Chemical type: Peptide from protein
Sequence: FLFGEPKRL
Position: 350-358
Source molecule (GenBank): P43364.2
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone
Reference: Gerald P Linette; Edward A Stadtmauer; Marcela V Maus; Aaron P Rapoport; Bruce L Levine; Lyndsey Emery; Leslie Litzky; Adam Bagg; Beatriz M Carreno; Patrick J Cimino; Gwendolyn K Binder-Scholl; Dominic P Smethurst; Andrew B Gerry; Nick J Pumphrey; Alan D Bennett; Joanna E Brewer; Joseph Dukes; Jane Harper; Helen K Tayton-Martin; Bent K Jakobsen; Namir J Hassan; Michael Kalos; Carl H June. "Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma." Blood (2013).

Epitope: MAGE-A3 peptide
Chemical type: Peptide from protein
Sequence: EVDPIGHLY
Position: 168-176
Source molecule (GenBank): E7EMU0.1
Assay category: TCell
Result: Positive
Cell type: T cell
Tissue: Blood
Culture conditions: Cell Line / Clone

Epitope: MAGE-A3 peptide
Chemical type: Peptide from protein
Sequence: EVDPIGHLY
Position: 168-176
Source molecule (GenBank): E7EMU0.1
Assay category: TCell
Result: Positive
Cell type: T cell CD3+
Tissue: Blood
Culture conditions: Direct Ex Vivo

Epitope: MAGE-A3 peptide
Chemical type: Peptide from protein
Sequence: EVDPIGHLY
Position: 168-176
Source molecule (GenBank): E7EMU0.1
Assay category: TCell
Result: Positive
Cell type: T cell
Tissue: Blood
Culture conditions: Cell Line / Clone
Reference: Xian Shen; Jinji Jin; Yujie Ding; Pengfei Wang; An Wang; Deshuan Xiao; Xiangyang Xue; Shanli Zhu; Lifang Zhang; Guanbao Zhu. "Novel immunodominant epitopes derived from MAGE-A3 and its significance in serological diagnosis of gastric cancer." Journal of cancer research and clinical oncology (2013).

Epitope: MAGE-A3 (112-131)
Chemical type: Peptide from protein
Sequence: KVAELVHFLLLKYRAREPVT
Position: 112-131
Source molecule (GenBank): P43357.1
Assay category: BCell
Result: Positive

Epitope: MAGE-A3 (112-131)
Chemical type: Peptide from protein
Sequence: KVAELVHFLLLKYRAREPVT
Position: 112-131
Source molecule (GenBank): P43357.1
Assay category: BCell
Result: Positive

Epitope: MAGE-A3 (112-131)
Chemical type: Peptide from protein
Sequence: KVAELVHFLLLKYRAREPVT
Position: 112-131
Source molecule (GenBank): P43357.1
Assay category: BCell
Result: Positive-Low

Epitope: MAGE-A3 (112-131)
Chemical type: Peptide from protein
Sequence: KVAELVHFLLLKYRAREPVT
Position: 112-131
Source molecule (GenBank): P43357.1
Assay category: BCell
Result: Positive-Low

Epitope: MAGE-A3 (232-246)
Chemical type: Peptide from protein
Sequence: EGREDSILGDPKKLL
Position: 232-246
Source molecule (GenBank): P43357.1
Assay category: BCell
Result: Positive

Epitope: MAGE-A3 (232-246)
Chemical type: Peptide from protein
Sequence: EGREDSILGDPKKLL
Position: 232-246
Source molecule (GenBank): P43357.1
Assay category: BCell
Result: Positive

Epitope: MAGE-A3 (232-246)
Chemical type: Peptide from protein
Sequence: EGREDSILGDPKKLL
Position: 232-246
Source molecule (GenBank): P43357.1
Assay category: BCell
Result: Positive-Low

Epitope: MAGE-A3 (232-246)
Chemical type: Peptide from protein
Sequence: EGREDSILGDPKKLL
Position: 232-246
Source molecule (GenBank): P43357.1
Assay category: BCell
Result: Positive-Low
Reference: Stephanie S Tseng-Rogenski; Mohamed S Arredouani; Yilin C Neeley; Bin Lu; Arul M Chinnaiyan; Martin G Sanda. "Fas-mediated T cell deletion potentiates tumor antigen-specific tolerance in a mouse model of prostate cancer." Cancer immunology, immunotherapy : CII (2008).

Epitope: Tag-epitope IV
Chemical type: Peptide from protein
Sequence: VVYDFLKC
Position: 404-411
Source molecule (GenBank): P03070.2
Assay category: TCell
Result: Negative
Host: M 
Cell type: splenocyte
Tissue: spleen
Culture conditions: Short Term Restimulated

Epitope: Tag-epitope IV
Chemical type: Peptide from protein
Sequence: VVYDFLKC
Position: 404-411
Source molecule (GenBank): P03070.2
Assay category: TCell
Result: Positive
Host: M 
Cell type: splenocyte
Tissue: spleen
Culture conditions: Short Term Restimulated

Epitope: Tag-epitope IV
Chemical type: Peptide from protein
Sequence: VVYDFLKC
Position: 404-411
Source molecule (GenBank): P03070.2
Assay category: TCell
Result: Positive
Host: M 
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Short Term Restimulated

Epitope: Tag-epitope IV
Chemical type: Peptide from protein
Sequence: VVYDFLKC
Position: 404-411
Source molecule (GenBank): P03070.2
Assay category: TCell
Result: Negative
Host: M 
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Short Term Restimulated

Epitope: Tag-epitope IV
Chemical type: Peptide from protein
Sequence: VVYDFLKC
Position: 404-411
Source molecule (GenBank): P03070.2
Assay category: MhcBinding
Result: Positive
Reference: Daniel J J Carr; Amanda N Berube; Adrian Filiberti; Grzegorz B Gmyrek. "Lack of neonatal Fc receptor does not diminish the efficacy of the HSV-1 0ΔNLS vaccine against ocular HSV-1 challenge." Vaccine (2021).

Epitope: gB
Chemical type: Peptide from protein
Sequence: SSIEFARL
Position: 499-506
Source molecule (GenBank): AAF04615.1
Assay category: TCell
Result: Negative
Host:  6-8 weeks
Cell type: T cell CD8+
Tissue: lymph node
Culture conditions: Direct Ex Vivo

Epitope: ICP6
Chemical type: Peptide from protein
Sequence: QTFDFGRL
Position: 822-829
Source molecule (GenBank): AAA45805.1
Assay category: TCell
Result: Negative
Host:  6-8 weeks
Cell type: T cell CD8+
Tissue: lymph node
Culture conditions: Direct Ex Vivo